Although it is not on the upcoming list of events, we cannot...

Although it is not on the upcoming list of events, we cannot discount the possibility of an update on Checkvacc progress. From what we heard LC talked about the patients on the trial, it does sound like they are doing nicely. So who knows, if the interim scan comes up with something definitive like 'complete remission' of first patient, they might let the market know when updating the dosing of third patient.

And then of course there is potential of a deal popping up. After all, the last few recent partnership trial with the likes of Merck, Pfizer and Roche were not expected by any of us.

So much happening in the background. Anything can pop. That is the norm here with IMU.